nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolcapone—Parkinson's disease—Bromocriptine—type 2 diabetes mellitus	0.481	1	CpDpCtD
Tolcapone—CYP2C9—Glimepiride—type 2 diabetes mellitus	0.0414	0.127	CbGbCtD
Tolcapone—CYP2C9—Glipizide—type 2 diabetes mellitus	0.0379	0.116	CbGbCtD
Tolcapone—CYP2C9—Gliclazide—type 2 diabetes mellitus	0.0352	0.108	CbGbCtD
Tolcapone—CYP2C9—Chlorpropamide—type 2 diabetes mellitus	0.0299	0.0916	CbGbCtD
Tolcapone—CYP2C9—Pioglitazone—type 2 diabetes mellitus	0.0299	0.0916	CbGbCtD
Tolcapone—CYP2C9—Rosiglitazone—type 2 diabetes mellitus	0.0276	0.0845	CbGbCtD
Tolcapone—CYP2C9—Tolbutamide—type 2 diabetes mellitus	0.0267	0.0816	CbGbCtD
Tolcapone—CYP2C9—Valsartan—type 2 diabetes mellitus	0.0244	0.0747	CbGbCtD
Tolcapone—CYP2C9—Nateglinide—type 2 diabetes mellitus	0.0227	0.0694	CbGbCtD
Tolcapone—CYP2C9—Irbesartan—type 2 diabetes mellitus	0.0218	0.0665	CbGbCtD
Tolcapone—CYP2C9—Glyburide—type 2 diabetes mellitus	0.0153	0.0469	CbGbCtD
Tolcapone—CYP2C9—Losartan—type 2 diabetes mellitus	0.014	0.0429	CbGbCtD
Tolcapone—Niclosamide—CYP1A2—type 2 diabetes mellitus	0.000686	0.72	CrCbGaD
Tolcapone—Tolmetin—PTGS2—type 2 diabetes mellitus	0.000266	0.28	CrCbGaD
Tolcapone—COMT—Neuronal System—GAD2—type 2 diabetes mellitus	0.000198	0.00473	CbGpPWpGaD
Tolcapone—COMT—Neuronal System—KCNJ11—type 2 diabetes mellitus	0.00018	0.00428	CbGpPWpGaD
Tolcapone—COMT—Biological oxidations—CYP2E1—type 2 diabetes mellitus	0.000172	0.00411	CbGpPWpGaD
Tolcapone—COMT—Biological oxidations—CYP1A2—type 2 diabetes mellitus	0.00017	0.00406	CbGpPWpGaD
Tolcapone—COMT—Metapathway biotransformation—CYP2E1—type 2 diabetes mellitus	0.00017	0.00405	CbGpPWpGaD
Tolcapone—COMT—Metapathway biotransformation—CYP1A2—type 2 diabetes mellitus	0.000168	0.00401	CbGpPWpGaD
Tolcapone—COMT—Transmission across Chemical Synapses—SNAP25—type 2 diabetes mellitus	0.000167	0.00398	CbGpPWpGaD
Tolcapone—COMT—Biological oxidations—CYP3A4—type 2 diabetes mellitus	0.000166	0.00396	CbGpPWpGaD
Tolcapone—COMT—Metapathway biotransformation—CYP3A4—type 2 diabetes mellitus	0.000164	0.00391	CbGpPWpGaD
Tolcapone—CYP2C9—Constitutive Androstane Receptor Pathway—CYP3A4—type 2 diabetes mellitus	0.000164	0.00391	CbGpPWpGaD
Tolcapone—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—type 2 diabetes mellitus	0.000162	0.00386	CbGpPWpGaD
Tolcapone—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—type 2 diabetes mellitus	0.00016	0.00382	CbGpPWpGaD
Tolcapone—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—type 2 diabetes mellitus	0.000156	0.00372	CbGpPWpGaD
Tolcapone—CYP2C9—Constitutive Androstane Receptor Pathway—PPARGC1A—type 2 diabetes mellitus	0.000139	0.00331	CbGpPWpGaD
Tolcapone—COMT—Biological oxidations—GSTM1—type 2 diabetes mellitus	0.000131	0.00311	CbGpPWpGaD
Tolcapone—COMT—Metapathway biotransformation—GSTM1—type 2 diabetes mellitus	0.000129	0.00307	CbGpPWpGaD
Tolcapone—COMT—Neuronal System—SNAP25—type 2 diabetes mellitus	0.000128	0.00305	CbGpPWpGaD
Tolcapone—COMT—Transmission across Chemical Synapses—GNB3—type 2 diabetes mellitus	0.000125	0.00298	CbGpPWpGaD
Tolcapone—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP11A1—type 2 diabetes mellitus	0.000124	0.00297	CbGpPWpGaD
Tolcapone—CYP2C9—Oxidation by Cytochrome P450—CYP11A1—type 2 diabetes mellitus	0.000123	0.00293	CbGpPWpGaD
Tolcapone—CYP2C9—Arachidonic acid metabolism—CYP1A2—type 2 diabetes mellitus	0.000118	0.0028	CbGpPWpGaD
Tolcapone—COMT—Transmission across Chemical Synapses—ADCY5—type 2 diabetes mellitus	0.000111	0.00265	CbGpPWpGaD
Tolcapone—CYP2C9—Biological oxidations—MAT1A—type 2 diabetes mellitus	0.000109	0.0026	CbGpPWpGaD
Tolcapone—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—type 2 diabetes mellitus	0.000106	0.00254	CbGpPWpGaD
Tolcapone—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2E1—type 2 diabetes mellitus	0.000103	0.00245	CbGpPWpGaD
Tolcapone—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A2—type 2 diabetes mellitus	0.000102	0.00242	CbGpPWpGaD
Tolcapone—CYP2C9—Oxidation by Cytochrome P450—CYP2E1—type 2 diabetes mellitus	0.000101	0.00242	CbGpPWpGaD
Tolcapone—CYP2C9—Phase 1 - Functionalization of compounds—CYP11A1—type 2 diabetes mellitus	0.000101	0.00241	CbGpPWpGaD
Tolcapone—CYP2C9—Oxidation by Cytochrome P450—CYP1A2—type 2 diabetes mellitus	0.0001	0.00239	CbGpPWpGaD
Tolcapone—COMT—Metabolism—BHMT—type 2 diabetes mellitus	9.96e-05	0.00238	CbGpPWpGaD
Tolcapone—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP3A4—type 2 diabetes mellitus	9.9e-05	0.00236	CbGpPWpGaD
Tolcapone—CYP2C9—Oxidation by Cytochrome P450—CYP3A4—type 2 diabetes mellitus	9.77e-05	0.00233	CbGpPWpGaD
Tolcapone—COMT—Neuronal System—GNB3—type 2 diabetes mellitus	9.56e-05	0.00228	CbGpPWpGaD
Tolcapone—COMT—Transmission across Chemical Synapses—CALM1—type 2 diabetes mellitus	9.55e-05	0.00228	CbGpPWpGaD
Tolcapone—COMT—Transmission across Chemical Synapses—PRKCB—type 2 diabetes mellitus	8.98e-05	0.00214	CbGpPWpGaD
Tolcapone—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—type 2 diabetes mellitus	8.79e-05	0.0021	CbGpPWpGaD
Tolcapone—COMT—Metabolism—PTGDS—type 2 diabetes mellitus	8.7e-05	0.00208	CbGpPWpGaD
Tolcapone—COMT—Metabolism—AANAT—type 2 diabetes mellitus	8.7e-05	0.00208	CbGpPWpGaD
Tolcapone—CYP2C9—Arachidonic acid metabolism—GPX1—type 2 diabetes mellitus	8.62e-05	0.00206	CbGpPWpGaD
Tolcapone—COMT—Neuronal System—ADCY5—type 2 diabetes mellitus	8.52e-05	0.00203	CbGpPWpGaD
Tolcapone—CYP2C9—Phase 1 - Functionalization of compounds—CYP2E1—type 2 diabetes mellitus	8.33e-05	0.00199	CbGpPWpGaD
Tolcapone—COMT—Metabolism—CDO1—type 2 diabetes mellitus	8.25e-05	0.00197	CbGpPWpGaD
Tolcapone—COMT—Metabolism—GPD2—type 2 diabetes mellitus	8.25e-05	0.00197	CbGpPWpGaD
Tolcapone—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A2—type 2 diabetes mellitus	8.23e-05	0.00196	CbGpPWpGaD
Tolcapone—CYP2C9—Phase 1 - Functionalization of compounds—CYP3A4—type 2 diabetes mellitus	8.03e-05	0.00192	CbGpPWpGaD
Tolcapone—COMT—Metabolism—AK1—type 2 diabetes mellitus	7.87e-05	0.00188	CbGpPWpGaD
Tolcapone—COMT—Neuronal System—CALM1—type 2 diabetes mellitus	7.32e-05	0.00175	CbGpPWpGaD
Tolcapone—COMT—Metabolism—SLC5A4—type 2 diabetes mellitus	7.26e-05	0.00173	CbGpPWpGaD
Tolcapone—COMT—Metabolism—MAT1A—type 2 diabetes mellitus	7.26e-05	0.00173	CbGpPWpGaD
Tolcapone—COMT—Metabolism—ND1—type 2 diabetes mellitus	7.02e-05	0.00167	CbGpPWpGaD
Tolcapone—COMT—Metabolism—G6PC—type 2 diabetes mellitus	7.02e-05	0.00167	CbGpPWpGaD
Tolcapone—COMT—Metabolism—PPP1R3C—type 2 diabetes mellitus	7.02e-05	0.00167	CbGpPWpGaD
Tolcapone—COMT—Metabolism—ENPP1—type 2 diabetes mellitus	7.02e-05	0.00167	CbGpPWpGaD
Tolcapone—COMT—Metabolism—HBA2—type 2 diabetes mellitus	7.02e-05	0.00167	CbGpPWpGaD
Tolcapone—COMT—Neuronal System—PRKCB—type 2 diabetes mellitus	6.88e-05	0.00164	CbGpPWpGaD
Tolcapone—COMT—Metabolism—GCGR—type 2 diabetes mellitus	6.79e-05	0.00162	CbGpPWpGaD
Tolcapone—COMT—Metabolism—CYTB—type 2 diabetes mellitus	6.42e-05	0.00153	CbGpPWpGaD
Tolcapone—COMT—Metabolism—OXCT1—type 2 diabetes mellitus	6.42e-05	0.00153	CbGpPWpGaD
Tolcapone—COMT—Metabolism—SRD5A1—type 2 diabetes mellitus	6.25e-05	0.00149	CbGpPWpGaD
Tolcapone—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	6.06e-05	0.000406	CcSEcCtD
Tolcapone—Paraesthesia—Valsartan—type 2 diabetes mellitus	6.04e-05	0.000405	CcSEcCtD
Tolcapone—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	6.03e-05	0.000404	CcSEcCtD
Tolcapone—Chest pain—Irbesartan—type 2 diabetes mellitus	6.03e-05	0.000404	CcSEcCtD
Tolcapone—Arthralgia—Irbesartan—type 2 diabetes mellitus	6.03e-05	0.000404	CcSEcCtD
Tolcapone—Myalgia—Irbesartan—type 2 diabetes mellitus	6.03e-05	0.000404	CcSEcCtD
Tolcapone—Shock—Metformin—type 2 diabetes mellitus	6.03e-05	0.000404	CcSEcCtD
Tolcapone—Malaise—Losartan—type 2 diabetes mellitus	6.01e-05	0.000403	CcSEcCtD
Tolcapone—Anxiety—Irbesartan—type 2 diabetes mellitus	6.01e-05	0.000403	CcSEcCtD
Tolcapone—Hypersensitivity—Glyburide—type 2 diabetes mellitus	6.01e-05	0.000403	CcSEcCtD
Tolcapone—Nervous system disorder—Metformin—type 2 diabetes mellitus	6.01e-05	0.000403	CcSEcCtD
Tolcapone—Thrombocytopenia—Metformin—type 2 diabetes mellitus	6e-05	0.000402	CcSEcCtD
Tolcapone—Dyspnoea—Valsartan—type 2 diabetes mellitus	6e-05	0.000402	CcSEcCtD
Tolcapone—Vertigo—Losartan—type 2 diabetes mellitus	5.99e-05	0.000401	CcSEcCtD
Tolcapone—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	5.99e-05	0.000401	CcSEcCtD
Tolcapone—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	5.99e-05	0.000401	CcSEcCtD
Tolcapone—Somnolence—Valsartan—type 2 diabetes mellitus	5.98e-05	0.000401	CcSEcCtD
Tolcapone—Syncope—Losartan—type 2 diabetes mellitus	5.98e-05	0.000401	CcSEcCtD
Tolcapone—Paraesthesia—Orlistat—type 2 diabetes mellitus	5.97e-05	0.0004	CcSEcCtD
Tolcapone—COMT—Metabolism—ACACA—type 2 diabetes mellitus	5.96e-05	0.00142	CbGpPWpGaD
Tolcapone—COMT—Metabolism—STAR—type 2 diabetes mellitus	5.96e-05	0.00142	CbGpPWpGaD
Tolcapone—COMT—Metabolism—HSD17B3—type 2 diabetes mellitus	5.96e-05	0.00142	CbGpPWpGaD
Tolcapone—Discomfort—Irbesartan—type 2 diabetes mellitus	5.96e-05	0.000399	CcSEcCtD
Tolcapone—Skin disorder—Metformin—type 2 diabetes mellitus	5.95e-05	0.000399	CcSEcCtD
Tolcapone—Hyperhidrosis—Metformin—type 2 diabetes mellitus	5.92e-05	0.000397	CcSEcCtD
Tolcapone—Dyspepsia—Valsartan—type 2 diabetes mellitus	5.92e-05	0.000397	CcSEcCtD
Tolcapone—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	5.92e-05	0.000396	CcSEcCtD
Tolcapone—Dizziness—Bromocriptine—type 2 diabetes mellitus	5.9e-05	0.000395	CcSEcCtD
Tolcapone—Dry mouth—Irbesartan—type 2 diabetes mellitus	5.9e-05	0.000395	CcSEcCtD
Tolcapone—Palpitations—Losartan—type 2 diabetes mellitus	5.89e-05	0.000395	CcSEcCtD
Tolcapone—Nausea—Glimepiride—type 2 diabetes mellitus	5.87e-05	0.000393	CcSEcCtD
Tolcapone—Arrhythmia—Ramipril—type 2 diabetes mellitus	5.87e-05	0.000393	CcSEcCtD
Tolcapone—Loss of consciousness—Losartan—type 2 diabetes mellitus	5.86e-05	0.000393	CcSEcCtD
Tolcapone—Nausea—Sitagliptin—type 2 diabetes mellitus	5.85e-05	0.000392	CcSEcCtD
Tolcapone—Dyspepsia—Orlistat—type 2 diabetes mellitus	5.85e-05	0.000392	CcSEcCtD
Tolcapone—Asthenia—Glyburide—type 2 diabetes mellitus	5.85e-05	0.000392	CcSEcCtD
Tolcapone—Decreased appetite—Valsartan—type 2 diabetes mellitus	5.85e-05	0.000392	CcSEcCtD
Tolcapone—Anorexia—Metformin—type 2 diabetes mellitus	5.84e-05	0.000391	CcSEcCtD
Tolcapone—Cough—Losartan—type 2 diabetes mellitus	5.82e-05	0.00039	CcSEcCtD
Tolcapone—Urticaria—Gliclazide—type 2 diabetes mellitus	5.82e-05	0.00039	CcSEcCtD
Tolcapone—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	5.81e-05	0.000389	CcSEcCtD
Tolcapone—Alopecia—Ramipril—type 2 diabetes mellitus	5.8e-05	0.000389	CcSEcCtD
Tolcapone—Fatigue—Valsartan—type 2 diabetes mellitus	5.8e-05	0.000389	CcSEcCtD
Tolcapone—Abdominal pain—Gliclazide—type 2 diabetes mellitus	5.79e-05	0.000388	CcSEcCtD
Tolcapone—Body temperature increased—Gliclazide—type 2 diabetes mellitus	5.79e-05	0.000388	CcSEcCtD
Tolcapone—Oedema—Irbesartan—type 2 diabetes mellitus	5.78e-05	0.000387	CcSEcCtD
Tolcapone—Decreased appetite—Orlistat—type 2 diabetes mellitus	5.78e-05	0.000387	CcSEcCtD
Tolcapone—Pruritus—Glyburide—type 2 diabetes mellitus	5.77e-05	0.000387	CcSEcCtD
Tolcapone—Mental disorder—Ramipril—type 2 diabetes mellitus	5.75e-05	0.000385	CcSEcCtD
Tolcapone—Constipation—Valsartan—type 2 diabetes mellitus	5.75e-05	0.000385	CcSEcCtD
Tolcapone—Infection—Irbesartan—type 2 diabetes mellitus	5.74e-05	0.000385	CcSEcCtD
Tolcapone—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	5.74e-05	0.000384	CcSEcCtD
Tolcapone—Fatigue—Orlistat—type 2 diabetes mellitus	5.73e-05	0.000384	CcSEcCtD
Tolcapone—Hypotension—Metformin—type 2 diabetes mellitus	5.72e-05	0.000384	CcSEcCtD
Tolcapone—COMT—Metabolism—CBS—type 2 diabetes mellitus	5.72e-05	0.00136	CbGpPWpGaD
Tolcapone—COMT—Metabolism—ABCC8—type 2 diabetes mellitus	5.72e-05	0.00136	CbGpPWpGaD
Tolcapone—Shock—Irbesartan—type 2 diabetes mellitus	5.69e-05	0.000381	CcSEcCtD
Tolcapone—Pain—Orlistat—type 2 diabetes mellitus	5.68e-05	0.000381	CcSEcCtD
Tolcapone—Arthralgia—Losartan—type 2 diabetes mellitus	5.67e-05	0.00038	CcSEcCtD
Tolcapone—Chest pain—Losartan—type 2 diabetes mellitus	5.67e-05	0.00038	CcSEcCtD
Tolcapone—Myalgia—Losartan—type 2 diabetes mellitus	5.67e-05	0.00038	CcSEcCtD
Tolcapone—Vomiting—Bromocriptine—type 2 diabetes mellitus	5.67e-05	0.00038	CcSEcCtD
Tolcapone—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	5.67e-05	0.00038	CcSEcCtD
Tolcapone—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	5.66e-05	0.000379	CcSEcCtD
Tolcapone—Anxiety—Losartan—type 2 diabetes mellitus	5.66e-05	0.000379	CcSEcCtD
Tolcapone—Tachycardia—Irbesartan—type 2 diabetes mellitus	5.64e-05	0.000378	CcSEcCtD
Tolcapone—Rash—Bromocriptine—type 2 diabetes mellitus	5.62e-05	0.000377	CcSEcCtD
Tolcapone—Dermatitis—Bromocriptine—type 2 diabetes mellitus	5.62e-05	0.000376	CcSEcCtD
Tolcapone—Skin disorder—Irbesartan—type 2 diabetes mellitus	5.61e-05	0.000376	CcSEcCtD
Tolcapone—Tension—Ramipril—type 2 diabetes mellitus	5.61e-05	0.000376	CcSEcCtD
Tolcapone—Discomfort—Losartan—type 2 diabetes mellitus	5.61e-05	0.000376	CcSEcCtD
Tolcapone—Dysgeusia—Ramipril—type 2 diabetes mellitus	5.6e-05	0.000375	CcSEcCtD
Tolcapone—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	5.59e-05	0.000374	CcSEcCtD
Tolcapone—Headache—Bromocriptine—type 2 diabetes mellitus	5.59e-05	0.000374	CcSEcCtD
Tolcapone—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	5.58e-05	0.000374	CcSEcCtD
Tolcapone—Diarrhoea—Glyburide—type 2 diabetes mellitus	5.58e-05	0.000374	CcSEcCtD
Tolcapone—Nervousness—Ramipril—type 2 diabetes mellitus	5.55e-05	0.000372	CcSEcCtD
Tolcapone—Dry mouth—Losartan—type 2 diabetes mellitus	5.55e-05	0.000372	CcSEcCtD
Tolcapone—CYP2C9—Biological oxidations—MTR—type 2 diabetes mellitus	5.53e-05	0.00132	CbGpPWpGaD
Tolcapone—Anorexia—Irbesartan—type 2 diabetes mellitus	5.51e-05	0.000369	CcSEcCtD
Tolcapone—COMT—Metabolism—SLC5A2—type 2 diabetes mellitus	5.5e-05	0.00131	CbGpPWpGaD
Tolcapone—COMT—Metabolism—COX2—type 2 diabetes mellitus	5.5e-05	0.00131	CbGpPWpGaD
Tolcapone—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	5.5e-05	0.000369	CcSEcCtD
Tolcapone—Paraesthesia—Metformin—type 2 diabetes mellitus	5.5e-05	0.000369	CcSEcCtD
Tolcapone—Muscle spasms—Ramipril—type 2 diabetes mellitus	5.49e-05	0.000368	CcSEcCtD
Tolcapone—Confusional state—Losartan—type 2 diabetes mellitus	5.49e-05	0.000368	CcSEcCtD
Tolcapone—Feeling abnormal—Orlistat—type 2 diabetes mellitus	5.48e-05	0.000367	CcSEcCtD
Tolcapone—Dyspnoea—Metformin—type 2 diabetes mellitus	5.46e-05	0.000366	CcSEcCtD
Tolcapone—Somnolence—Metformin—type 2 diabetes mellitus	5.45e-05	0.000365	CcSEcCtD
Tolcapone—Oedema—Losartan—type 2 diabetes mellitus	5.44e-05	0.000365	CcSEcCtD
Tolcapone—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	5.43e-05	0.000364	CcSEcCtD
Tolcapone—COMT—Metabolism—NCOA6—type 2 diabetes mellitus	5.41e-05	0.00129	CbGpPWpGaD
Tolcapone—Infection—Losartan—type 2 diabetes mellitus	5.4e-05	0.000362	CcSEcCtD
Tolcapone—Hypotension—Irbesartan—type 2 diabetes mellitus	5.4e-05	0.000362	CcSEcCtD
Tolcapone—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	5.39e-05	0.000361	CcSEcCtD
Tolcapone—Dyspepsia—Metformin—type 2 diabetes mellitus	5.39e-05	0.000361	CcSEcCtD
Tolcapone—CYP2C9—Biological oxidations—CYP11A1—type 2 diabetes mellitus	5.36e-05	0.00128	CbGpPWpGaD
Tolcapone—Tremor—Ramipril—type 2 diabetes mellitus	5.35e-05	0.000359	CcSEcCtD
Tolcapone—Shock—Losartan—type 2 diabetes mellitus	5.35e-05	0.000359	CcSEcCtD
Tolcapone—Urticaria—Valsartan—type 2 diabetes mellitus	5.34e-05	0.000358	CcSEcCtD
Tolcapone—Nervous system disorder—Losartan—type 2 diabetes mellitus	5.33e-05	0.000357	CcSEcCtD
Tolcapone—Thrombocytopenia—Losartan—type 2 diabetes mellitus	5.33e-05	0.000357	CcSEcCtD
Tolcapone—Decreased appetite—Metformin—type 2 diabetes mellitus	5.32e-05	0.000357	CcSEcCtD
Tolcapone—Abdominal pain—Valsartan—type 2 diabetes mellitus	5.32e-05	0.000356	CcSEcCtD
Tolcapone—COMT—Metabolism—UCP2—type 2 diabetes mellitus	5.32e-05	0.00127	CbGpPWpGaD
Tolcapone—COMT—Metabolism—UCP3—type 2 diabetes mellitus	5.32e-05	0.00127	CbGpPWpGaD
Tolcapone—COMT—Metabolism—HSD11B1—type 2 diabetes mellitus	5.32e-05	0.00127	CbGpPWpGaD
Tolcapone—Tachycardia—Losartan—type 2 diabetes mellitus	5.31e-05	0.000356	CcSEcCtD
Tolcapone—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	5.3e-05	0.000355	CcSEcCtD
Tolcapone—Nausea—Bromocriptine—type 2 diabetes mellitus	5.3e-05	0.000355	CcSEcCtD
Tolcapone—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	5.29e-05	0.000354	CcSEcCtD
Tolcapone—CYP2C9—Metapathway biotransformation—CYP11A1—type 2 diabetes mellitus	5.28e-05	0.00126	CbGpPWpGaD
Tolcapone—Fatigue—Metformin—type 2 diabetes mellitus	5.28e-05	0.000354	CcSEcCtD
Tolcapone—Urticaria—Orlistat—type 2 diabetes mellitus	5.28e-05	0.000354	CcSEcCtD
Tolcapone—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	5.27e-05	0.000353	CcSEcCtD
Tolcapone—Hyperhidrosis—Losartan—type 2 diabetes mellitus	5.26e-05	0.000352	CcSEcCtD
Tolcapone—Abdominal pain—Orlistat—type 2 diabetes mellitus	5.25e-05	0.000352	CcSEcCtD
Tolcapone—Body temperature increased—Orlistat—type 2 diabetes mellitus	5.25e-05	0.000352	CcSEcCtD
Tolcapone—Asthenia—Gliclazide—type 2 diabetes mellitus	5.25e-05	0.000352	CcSEcCtD
Tolcapone—Agitation—Ramipril—type 2 diabetes mellitus	5.25e-05	0.000352	CcSEcCtD
Tolcapone—Constipation—Metformin—type 2 diabetes mellitus	5.24e-05	0.000351	CcSEcCtD
Tolcapone—Paraesthesia—Irbesartan—type 2 diabetes mellitus	5.19e-05	0.000348	CcSEcCtD
Tolcapone—Anorexia—Losartan—type 2 diabetes mellitus	5.19e-05	0.000347	CcSEcCtD
Tolcapone—Vomiting—Glyburide—type 2 diabetes mellitus	5.18e-05	0.000347	CcSEcCtD
Tolcapone—Pruritus—Gliclazide—type 2 diabetes mellitus	5.18e-05	0.000347	CcSEcCtD
Tolcapone—Malaise—Ramipril—type 2 diabetes mellitus	5.15e-05	0.000345	CcSEcCtD
Tolcapone—Dyspnoea—Irbesartan—type 2 diabetes mellitus	5.15e-05	0.000345	CcSEcCtD
Tolcapone—Rash—Glyburide—type 2 diabetes mellitus	5.14e-05	0.000344	CcSEcCtD
Tolcapone—Somnolence—Irbesartan—type 2 diabetes mellitus	5.14e-05	0.000344	CcSEcCtD
Tolcapone—Dermatitis—Glyburide—type 2 diabetes mellitus	5.14e-05	0.000344	CcSEcCtD
Tolcapone—Vertigo—Ramipril—type 2 diabetes mellitus	5.13e-05	0.000344	CcSEcCtD
Tolcapone—Syncope—Ramipril—type 2 diabetes mellitus	5.13e-05	0.000343	CcSEcCtD
Tolcapone—Headache—Glyburide—type 2 diabetes mellitus	5.11e-05	0.000342	CcSEcCtD
Tolcapone—Dyspepsia—Irbesartan—type 2 diabetes mellitus	5.09e-05	0.000341	CcSEcCtD
Tolcapone—Hypotension—Losartan—type 2 diabetes mellitus	5.08e-05	0.000341	CcSEcCtD
Tolcapone—CYP2C9—Arachidonic acid metabolism—PTGS2—type 2 diabetes mellitus	5.08e-05	0.00121	CbGpPWpGaD
Tolcapone—Palpitations—Ramipril—type 2 diabetes mellitus	5.05e-05	0.000338	CcSEcCtD
Tolcapone—Feeling abnormal—Metformin—type 2 diabetes mellitus	5.05e-05	0.000338	CcSEcCtD
Tolcapone—Decreased appetite—Irbesartan—type 2 diabetes mellitus	5.02e-05	0.000337	CcSEcCtD
Tolcapone—Loss of consciousness—Ramipril—type 2 diabetes mellitus	5.02e-05	0.000337	CcSEcCtD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—PTGDS—type 2 diabetes mellitus	5.02e-05	0.0012	CbGpPWpGaD
Tolcapone—Diarrhoea—Gliclazide—type 2 diabetes mellitus	5.01e-05	0.000336	CcSEcCtD
Tolcapone—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	5.01e-05	0.000336	CcSEcCtD
Tolcapone—COMT—Metabolism—PCK1—type 2 diabetes mellitus	5e-05	0.00119	CbGpPWpGaD
Tolcapone—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	4.99e-05	0.000334	CcSEcCtD
Tolcapone—Cough—Ramipril—type 2 diabetes mellitus	4.99e-05	0.000334	CcSEcCtD
Tolcapone—Fatigue—Irbesartan—type 2 diabetes mellitus	4.98e-05	0.000334	CcSEcCtD
Tolcapone—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	4.96e-05	0.000332	CcSEcCtD
Tolcapone—Hypersensitivity—Valsartan—type 2 diabetes mellitus	4.96e-05	0.000332	CcSEcCtD
Tolcapone—Constipation—Irbesartan—type 2 diabetes mellitus	4.94e-05	0.000331	CcSEcCtD
Tolcapone—Pain—Irbesartan—type 2 diabetes mellitus	4.94e-05	0.000331	CcSEcCtD
Tolcapone—Hypersensitivity—Orlistat—type 2 diabetes mellitus	4.9e-05	0.000328	CcSEcCtD
Tolcapone—Paraesthesia—Losartan—type 2 diabetes mellitus	4.88e-05	0.000327	CcSEcCtD
Tolcapone—Urticaria—Metformin—type 2 diabetes mellitus	4.87e-05	0.000326	CcSEcCtD
Tolcapone—Myalgia—Ramipril—type 2 diabetes mellitus	4.87e-05	0.000326	CcSEcCtD
Tolcapone—Arthralgia—Ramipril—type 2 diabetes mellitus	4.87e-05	0.000326	CcSEcCtD
Tolcapone—Chest pain—Ramipril—type 2 diabetes mellitus	4.87e-05	0.000326	CcSEcCtD
Tolcapone—Dyspnoea—Losartan—type 2 diabetes mellitus	4.85e-05	0.000325	CcSEcCtD
Tolcapone—Anxiety—Ramipril—type 2 diabetes mellitus	4.85e-05	0.000325	CcSEcCtD
Tolcapone—Nausea—Glyburide—type 2 diabetes mellitus	4.84e-05	0.000325	CcSEcCtD
Tolcapone—Abdominal pain—Metformin—type 2 diabetes mellitus	4.84e-05	0.000324	CcSEcCtD
Tolcapone—Dizziness—Gliclazide—type 2 diabetes mellitus	4.84e-05	0.000324	CcSEcCtD
Tolcapone—Somnolence—Losartan—type 2 diabetes mellitus	4.84e-05	0.000324	CcSEcCtD
Tolcapone—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	4.83e-05	0.000324	CcSEcCtD
Tolcapone—Asthenia—Valsartan—type 2 diabetes mellitus	4.83e-05	0.000323	CcSEcCtD
Tolcapone—Discomfort—Ramipril—type 2 diabetes mellitus	4.81e-05	0.000322	CcSEcCtD
Tolcapone—Dyspepsia—Losartan—type 2 diabetes mellitus	4.79e-05	0.000321	CcSEcCtD
Tolcapone—Asthenia—Orlistat—type 2 diabetes mellitus	4.77e-05	0.00032	CcSEcCtD
Tolcapone—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	4.76e-05	0.000319	CcSEcCtD
Tolcapone—Pruritus—Valsartan—type 2 diabetes mellitus	4.76e-05	0.000319	CcSEcCtD
Tolcapone—Dry mouth—Ramipril—type 2 diabetes mellitus	4.76e-05	0.000319	CcSEcCtD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—GPD2—type 2 diabetes mellitus	4.76e-05	0.00113	CbGpPWpGaD
Tolcapone—Decreased appetite—Losartan—type 2 diabetes mellitus	4.73e-05	0.000317	CcSEcCtD
Tolcapone—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	4.73e-05	0.000317	CcSEcCtD
Tolcapone—Confusional state—Ramipril—type 2 diabetes mellitus	4.7e-05	0.000315	CcSEcCtD
Tolcapone—Pruritus—Orlistat—type 2 diabetes mellitus	4.7e-05	0.000315	CcSEcCtD
Tolcapone—Fatigue—Losartan—type 2 diabetes mellitus	4.69e-05	0.000314	CcSEcCtD
Tolcapone—COMT—Metabolism—HK1—type 2 diabetes mellitus	4.68e-05	0.00112	CbGpPWpGaD
Tolcapone—Oedema—Ramipril—type 2 diabetes mellitus	4.66e-05	0.000313	CcSEcCtD
Tolcapone—Vomiting—Gliclazide—type 2 diabetes mellitus	4.65e-05	0.000312	CcSEcCtD
Tolcapone—Constipation—Losartan—type 2 diabetes mellitus	4.65e-05	0.000312	CcSEcCtD
Tolcapone—Pain—Losartan—type 2 diabetes mellitus	4.65e-05	0.000312	CcSEcCtD
Tolcapone—Rash—Gliclazide—type 2 diabetes mellitus	4.62e-05	0.000309	CcSEcCtD
Tolcapone—Dermatitis—Gliclazide—type 2 diabetes mellitus	4.61e-05	0.000309	CcSEcCtD
Tolcapone—Diarrhoea—Valsartan—type 2 diabetes mellitus	4.6e-05	0.000308	CcSEcCtD
Tolcapone—Urticaria—Irbesartan—type 2 diabetes mellitus	4.59e-05	0.000308	CcSEcCtD
Tolcapone—Shock—Ramipril—type 2 diabetes mellitus	4.59e-05	0.000308	CcSEcCtD
Tolcapone—Headache—Gliclazide—type 2 diabetes mellitus	4.59e-05	0.000307	CcSEcCtD
Tolcapone—Nervous system disorder—Ramipril—type 2 diabetes mellitus	4.57e-05	0.000307	CcSEcCtD
Tolcapone—Abdominal pain—Irbesartan—type 2 diabetes mellitus	4.57e-05	0.000306	CcSEcCtD
Tolcapone—Body temperature increased—Irbesartan—type 2 diabetes mellitus	4.57e-05	0.000306	CcSEcCtD
Tolcapone—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	4.57e-05	0.000306	CcSEcCtD
Tolcapone—Tachycardia—Ramipril—type 2 diabetes mellitus	4.55e-05	0.000305	CcSEcCtD
Tolcapone—Diarrhoea—Orlistat—type 2 diabetes mellitus	4.55e-05	0.000305	CcSEcCtD
Tolcapone—Skin disorder—Ramipril—type 2 diabetes mellitus	4.53e-05	0.000304	CcSEcCtD
Tolcapone—COMT—Metabolism—HSD3B2—type 2 diabetes mellitus	4.52e-05	0.00108	CbGpPWpGaD
Tolcapone—COMT—Metabolism—LPA—type 2 diabetes mellitus	4.52e-05	0.00108	CbGpPWpGaD
Tolcapone—COMT—Metabolism—GCKR—type 2 diabetes mellitus	4.52e-05	0.00108	CbGpPWpGaD
Tolcapone—COMT—Metabolism—KCNJ11—type 2 diabetes mellitus	4.52e-05	0.00108	CbGpPWpGaD
Tolcapone—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	4.51e-05	0.000302	CcSEcCtD
Tolcapone—Feeling abnormal—Losartan—type 2 diabetes mellitus	4.48e-05	0.0003	CcSEcCtD
Tolcapone—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	4.45e-05	0.000298	CcSEcCtD
Tolcapone—Dizziness—Valsartan—type 2 diabetes mellitus	4.45e-05	0.000298	CcSEcCtD
Tolcapone—Anorexia—Ramipril—type 2 diabetes mellitus	4.45e-05	0.000298	CcSEcCtD
Tolcapone—CYP2C9—Biological oxidations—CYP2E1—type 2 diabetes mellitus	4.42e-05	0.00105	CbGpPWpGaD
Tolcapone—Dizziness—Orlistat—type 2 diabetes mellitus	4.4e-05	0.000295	CcSEcCtD
Tolcapone—Asthenia—Metformin—type 2 diabetes mellitus	4.39e-05	0.000294	CcSEcCtD
Tolcapone—CYP2C9—Biological oxidations—CYP1A2—type 2 diabetes mellitus	4.37e-05	0.00104	CbGpPWpGaD
Tolcapone—CYP2C9—Metapathway biotransformation—CYP2E1—type 2 diabetes mellitus	4.36e-05	0.00104	CbGpPWpGaD
Tolcapone—Hypotension—Ramipril—type 2 diabetes mellitus	4.36e-05	0.000292	CcSEcCtD
Tolcapone—Nausea—Gliclazide—type 2 diabetes mellitus	4.35e-05	0.000291	CcSEcCtD
Tolcapone—COMT—Metabolism—ALDOB—type 2 diabetes mellitus	4.33e-05	0.00103	CbGpPWpGaD
Tolcapone—Pruritus—Metformin—type 2 diabetes mellitus	4.33e-05	0.00029	CcSEcCtD
Tolcapone—Urticaria—Losartan—type 2 diabetes mellitus	4.32e-05	0.00029	CcSEcCtD
Tolcapone—CYP2C9—Metapathway biotransformation—CYP1A2—type 2 diabetes mellitus	4.31e-05	0.00103	CbGpPWpGaD
Tolcapone—Abdominal pain—Losartan—type 2 diabetes mellitus	4.3e-05	0.000288	CcSEcCtD
Tolcapone—Body temperature increased—Losartan—type 2 diabetes mellitus	4.3e-05	0.000288	CcSEcCtD
Tolcapone—Vomiting—Valsartan—type 2 diabetes mellitus	4.28e-05	0.000287	CcSEcCtD
Tolcapone—CYP2C9—Biological oxidations—CYP3A4—type 2 diabetes mellitus	4.26e-05	0.00102	CbGpPWpGaD
Tolcapone—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	4.26e-05	0.000285	CcSEcCtD
Tolcapone—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	4.25e-05	0.000285	CcSEcCtD
Tolcapone—Rash—Valsartan—type 2 diabetes mellitus	4.24e-05	0.000284	CcSEcCtD
Tolcapone—Dermatitis—Valsartan—type 2 diabetes mellitus	4.24e-05	0.000284	CcSEcCtD
Tolcapone—Vomiting—Orlistat—type 2 diabetes mellitus	4.23e-05	0.000283	CcSEcCtD
Tolcapone—Headache—Valsartan—type 2 diabetes mellitus	4.21e-05	0.000282	CcSEcCtD
Tolcapone—CYP2C9—Metapathway biotransformation—CYP3A4—type 2 diabetes mellitus	4.21e-05	0.001	CbGpPWpGaD
Tolcapone—Diarrhoea—Metformin—type 2 diabetes mellitus	4.19e-05	0.000281	CcSEcCtD
Tolcapone—Rash—Orlistat—type 2 diabetes mellitus	4.19e-05	0.000281	CcSEcCtD
Tolcapone—Paraesthesia—Ramipril—type 2 diabetes mellitus	4.19e-05	0.000281	CcSEcCtD
Tolcapone—Dermatitis—Orlistat—type 2 diabetes mellitus	4.19e-05	0.000281	CcSEcCtD
Tolcapone—Headache—Orlistat—type 2 diabetes mellitus	4.16e-05	0.000279	CcSEcCtD
Tolcapone—Dyspnoea—Ramipril—type 2 diabetes mellitus	4.16e-05	0.000279	CcSEcCtD
Tolcapone—Asthenia—Irbesartan—type 2 diabetes mellitus	4.15e-05	0.000278	CcSEcCtD
Tolcapone—Somnolence—Ramipril—type 2 diabetes mellitus	4.15e-05	0.000278	CcSEcCtD
Tolcapone—Dyspepsia—Ramipril—type 2 diabetes mellitus	4.11e-05	0.000275	CcSEcCtD
Tolcapone—Pruritus—Irbesartan—type 2 diabetes mellitus	4.09e-05	0.000274	CcSEcCtD
Tolcapone—Decreased appetite—Ramipril—type 2 diabetes mellitus	4.05e-05	0.000272	CcSEcCtD
Tolcapone—Dizziness—Metformin—type 2 diabetes mellitus	4.05e-05	0.000271	CcSEcCtD
Tolcapone—COMT—Metabolism—GLP1R—type 2 diabetes mellitus	4.03e-05	0.000961	CbGpPWpGaD
Tolcapone—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	4.03e-05	0.00027	CcSEcCtD
Tolcapone—Fatigue—Ramipril—type 2 diabetes mellitus	4.02e-05	0.000269	CcSEcCtD
Tolcapone—Hypersensitivity—Losartan—type 2 diabetes mellitus	4.01e-05	0.000269	CcSEcCtD
Tolcapone—Nausea—Valsartan—type 2 diabetes mellitus	4e-05	0.000268	CcSEcCtD
Tolcapone—Constipation—Ramipril—type 2 diabetes mellitus	3.99e-05	0.000267	CcSEcCtD
Tolcapone—Diarrhoea—Irbesartan—type 2 diabetes mellitus	3.95e-05	0.000265	CcSEcCtD
Tolcapone—Nausea—Orlistat—type 2 diabetes mellitus	3.95e-05	0.000265	CcSEcCtD
Tolcapone—Asthenia—Losartan—type 2 diabetes mellitus	3.9e-05	0.000262	CcSEcCtD
Tolcapone—Vomiting—Metformin—type 2 diabetes mellitus	3.89e-05	0.000261	CcSEcCtD
Tolcapone—Rash—Metformin—type 2 diabetes mellitus	3.86e-05	0.000259	CcSEcCtD
Tolcapone—Dermatitis—Metformin—type 2 diabetes mellitus	3.86e-05	0.000259	CcSEcCtD
Tolcapone—Pruritus—Losartan—type 2 diabetes mellitus	3.85e-05	0.000258	CcSEcCtD
Tolcapone—Feeling abnormal—Ramipril—type 2 diabetes mellitus	3.84e-05	0.000258	CcSEcCtD
Tolcapone—Headache—Metformin—type 2 diabetes mellitus	3.84e-05	0.000257	CcSEcCtD
Tolcapone—Dizziness—Irbesartan—type 2 diabetes mellitus	3.82e-05	0.000256	CcSEcCtD
Tolcapone—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	3.81e-05	0.000256	CcSEcCtD
Tolcapone—COMT—Metabolism—SLC2A2—type 2 diabetes mellitus	3.76e-05	0.000897	CbGpPWpGaD
Tolcapone—Diarrhoea—Losartan—type 2 diabetes mellitus	3.72e-05	0.000249	CcSEcCtD
Tolcapone—Urticaria—Ramipril—type 2 diabetes mellitus	3.71e-05	0.000248	CcSEcCtD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—OXCT1—type 2 diabetes mellitus	3.7e-05	0.000882	CbGpPWpGaD
Tolcapone—Abdominal pain—Ramipril—type 2 diabetes mellitus	3.69e-05	0.000247	CcSEcCtD
Tolcapone—Body temperature increased—Ramipril—type 2 diabetes mellitus	3.69e-05	0.000247	CcSEcCtD
Tolcapone—COMT—Metabolism—MTR—type 2 diabetes mellitus	3.69e-05	0.000879	CbGpPWpGaD
Tolcapone—COMT—Metabolism—CPT1A—type 2 diabetes mellitus	3.69e-05	0.000879	CbGpPWpGaD
Tolcapone—Vomiting—Irbesartan—type 2 diabetes mellitus	3.68e-05	0.000246	CcSEcCtD
Tolcapone—Rash—Irbesartan—type 2 diabetes mellitus	3.64e-05	0.000244	CcSEcCtD
Tolcapone—Dermatitis—Irbesartan—type 2 diabetes mellitus	3.64e-05	0.000244	CcSEcCtD
Tolcapone—Nausea—Metformin—type 2 diabetes mellitus	3.64e-05	0.000244	CcSEcCtD
Tolcapone—Headache—Irbesartan—type 2 diabetes mellitus	3.62e-05	0.000243	CcSEcCtD
Tolcapone—COMT—Metabolism—NAMPT—type 2 diabetes mellitus	3.61e-05	0.000862	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—SRD5A1—type 2 diabetes mellitus	3.6e-05	0.00086	CbGpPWpGaD
Tolcapone—Dizziness—Losartan—type 2 diabetes mellitus	3.6e-05	0.000241	CcSEcCtD
Tolcapone—COMT—Metabolism—LIPC—type 2 diabetes mellitus	3.59e-05	0.000857	CbGpPWpGaD
Tolcapone—COMT—Metabolism—HBA1—type 2 diabetes mellitus	3.59e-05	0.000857	CbGpPWpGaD
Tolcapone—COMT—Metabolism—GCK—type 2 diabetes mellitus	3.59e-05	0.000857	CbGpPWpGaD
Tolcapone—COMT—Metabolism—CYP11A1—type 2 diabetes mellitus	3.57e-05	0.000851	CbGpPWpGaD
Tolcapone—COMT—Metabolism—SLC9A1—type 2 diabetes mellitus	3.51e-05	0.000836	CbGpPWpGaD
Tolcapone—COMT—Metabolism—CETP—type 2 diabetes mellitus	3.46e-05	0.000826	CbGpPWpGaD
Tolcapone—Vomiting—Losartan—type 2 diabetes mellitus	3.46e-05	0.000232	CcSEcCtD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—ACACA—type 2 diabetes mellitus	3.44e-05	0.00082	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—HSD17B3—type 2 diabetes mellitus	3.44e-05	0.00082	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—STAR—type 2 diabetes mellitus	3.44e-05	0.00082	CbGpPWpGaD
Tolcapone—Hypersensitivity—Ramipril—type 2 diabetes mellitus	3.44e-05	0.00023	CcSEcCtD
Tolcapone—Nausea—Irbesartan—type 2 diabetes mellitus	3.43e-05	0.00023	CcSEcCtD
Tolcapone—Rash—Losartan—type 2 diabetes mellitus	3.43e-05	0.00023	CcSEcCtD
Tolcapone—Dermatitis—Losartan—type 2 diabetes mellitus	3.43e-05	0.00023	CcSEcCtD
Tolcapone—Headache—Losartan—type 2 diabetes mellitus	3.41e-05	0.000228	CcSEcCtD
Tolcapone—CYP2C9—Biological oxidations—GSTM1—type 2 diabetes mellitus	3.35e-05	0.0008	CbGpPWpGaD
Tolcapone—Asthenia—Ramipril—type 2 diabetes mellitus	3.35e-05	0.000224	CcSEcCtD
Tolcapone—CYP2C9—Metapathway biotransformation—GSTM1—type 2 diabetes mellitus	3.31e-05	0.000789	CbGpPWpGaD
Tolcapone—Pruritus—Ramipril—type 2 diabetes mellitus	3.3e-05	0.000221	CcSEcCtD
Tolcapone—Nausea—Losartan—type 2 diabetes mellitus	3.23e-05	0.000217	CcSEcCtD
Tolcapone—COMT—Metabolism—PSMD6—type 2 diabetes mellitus	3.22e-05	0.000768	CbGpPWpGaD
Tolcapone—COMT—Metabolism—SREBF1—type 2 diabetes mellitus	3.22e-05	0.000768	CbGpPWpGaD
Tolcapone—COMT—Metabolism—SNAP25—type 2 diabetes mellitus	3.22e-05	0.000768	CbGpPWpGaD
Tolcapone—Diarrhoea—Ramipril—type 2 diabetes mellitus	3.19e-05	0.000214	CcSEcCtD
Tolcapone—COMT—Metabolism—CTGF—type 2 diabetes mellitus	3.16e-05	0.000754	CbGpPWpGaD
Tolcapone—COMT—Metabolism—HMGCR—type 2 diabetes mellitus	3.13e-05	0.000747	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—NCOA6—type 2 diabetes mellitus	3.12e-05	0.000744	CbGpPWpGaD
Tolcapone—Dizziness—Ramipril—type 2 diabetes mellitus	3.08e-05	0.000207	CcSEcCtD
Tolcapone—COMT—Metabolism—ADRA2A—type 2 diabetes mellitus	3.07e-05	0.000731	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—HSD11B1—type 2 diabetes mellitus	3.06e-05	0.000731	CbGpPWpGaD
Tolcapone—Vomiting—Ramipril—type 2 diabetes mellitus	2.97e-05	0.000199	CcSEcCtD
Tolcapone—COMT—Metabolism—CYP2E1—type 2 diabetes mellitus	2.95e-05	0.000703	CbGpPWpGaD
Tolcapone—Rash—Ramipril—type 2 diabetes mellitus	2.94e-05	0.000197	CcSEcCtD
Tolcapone—Dermatitis—Ramipril—type 2 diabetes mellitus	2.94e-05	0.000197	CcSEcCtD
Tolcapone—Headache—Ramipril—type 2 diabetes mellitus	2.92e-05	0.000196	CcSEcCtD
Tolcapone—COMT—Metabolism—SLC2A1—type 2 diabetes mellitus	2.91e-05	0.000695	CbGpPWpGaD
Tolcapone—COMT—Metabolism—CYP1A2—type 2 diabetes mellitus	2.91e-05	0.000695	CbGpPWpGaD
Tolcapone—COMT—Metabolism—CYP3A4—type 2 diabetes mellitus	2.84e-05	0.000678	CbGpPWpGaD
Tolcapone—COMT—Metabolism—SLC2A4—type 2 diabetes mellitus	2.79e-05	0.000666	CbGpPWpGaD
Tolcapone—COMT—Metabolism—GCG—type 2 diabetes mellitus	2.79e-05	0.000666	CbGpPWpGaD
Tolcapone—Nausea—Ramipril—type 2 diabetes mellitus	2.77e-05	0.000186	CcSEcCtD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—HSD3B2—type 2 diabetes mellitus	2.61e-05	0.000622	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—LPA—type 2 diabetes mellitus	2.61e-05	0.000622	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—BHMT—type 2 diabetes mellitus	2.56e-05	0.00061	CbGpPWpGaD
Tolcapone—COMT—Metabolism—GNB3—type 2 diabetes mellitus	2.41e-05	0.000574	CbGpPWpGaD
Tolcapone—COMT—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.41e-05	0.000574	CbGpPWpGaD
Tolcapone—COMT—Metabolism—HMOX1—type 2 diabetes mellitus	2.4e-05	0.000572	CbGpPWpGaD
Tolcapone—COMT—Metabolism—CAT—type 2 diabetes mellitus	2.36e-05	0.000564	CbGpPWpGaD
Tolcapone—COMT—Metabolism—APOB—type 2 diabetes mellitus	2.3e-05	0.000547	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—PTGDS—type 2 diabetes mellitus	2.23e-05	0.000533	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—AANAT—type 2 diabetes mellitus	2.23e-05	0.000533	CbGpPWpGaD
Tolcapone—COMT—Metabolism—GSTM1—type 2 diabetes mellitus	2.23e-05	0.000533	CbGpPWpGaD
Tolcapone—COMT—Metabolism—LPL—type 2 diabetes mellitus	2.19e-05	0.000523	CbGpPWpGaD
Tolcapone—COMT—Metabolism—ADCY5—type 2 diabetes mellitus	2.15e-05	0.000512	CbGpPWpGaD
Tolcapone—COMT—Metabolism—GPX1—type 2 diabetes mellitus	2.14e-05	0.00051	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—CPT1A—type 2 diabetes mellitus	2.12e-05	0.000507	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—CDO1—type 2 diabetes mellitus	2.12e-05	0.000505	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—GPD2—type 2 diabetes mellitus	2.12e-05	0.000505	CbGpPWpGaD
Tolcapone—COMT—Metabolism—CD36—type 2 diabetes mellitus	2.08e-05	0.000497	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—LIPC—type 2 diabetes mellitus	2.07e-05	0.000494	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—type 2 diabetes mellitus	2.06e-05	0.000491	CbGpPWpGaD
Tolcapone—COMT—Metabolism—PPP2CA—type 2 diabetes mellitus	2.06e-05	0.00049	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—AK1—type 2 diabetes mellitus	2.02e-05	0.000482	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—CETP—type 2 diabetes mellitus	2e-05	0.000476	CbGpPWpGaD
Tolcapone—COMT—Metabolism—MTHFR—type 2 diabetes mellitus	1.97e-05	0.000471	CbGpPWpGaD
Tolcapone—COMT—Metabolism—PPARA—type 2 diabetes mellitus	1.94e-05	0.000462	CbGpPWpGaD
Tolcapone—COMT—Metabolism—AGT—type 2 diabetes mellitus	1.87e-05	0.000447	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—SLC5A4—type 2 diabetes mellitus	1.86e-05	0.000445	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—MAT1A—type 2 diabetes mellitus	1.86e-05	0.000445	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—SREBF1—type 2 diabetes mellitus	1.86e-05	0.000443	CbGpPWpGaD
Tolcapone—COMT—Metabolism—CALM1—type 2 diabetes mellitus	1.84e-05	0.00044	CbGpPWpGaD
Tolcapone—COMT—Metabolism—APOE—type 2 diabetes mellitus	1.84e-05	0.000438	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—type 2 diabetes mellitus	1.82e-05	0.000435	CbGpPWpGaD
Tolcapone—COMT—Metabolism—APOA1—type 2 diabetes mellitus	1.82e-05	0.000433	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—HMGCR—type 2 diabetes mellitus	1.81e-05	0.000431	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—HBA2—type 2 diabetes mellitus	1.8e-05	0.00043	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—ND1—type 2 diabetes mellitus	1.8e-05	0.00043	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—ENPP1—type 2 diabetes mellitus	1.8e-05	0.00043	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—G6PC—type 2 diabetes mellitus	1.8e-05	0.00043	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—PPP1R3C—type 2 diabetes mellitus	1.8e-05	0.00043	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—GCGR—type 2 diabetes mellitus	1.74e-05	0.000416	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—type 2 diabetes mellitus	1.68e-05	0.000401	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—CYTB—type 2 diabetes mellitus	1.65e-05	0.000393	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—OXCT1—type 2 diabetes mellitus	1.65e-05	0.000393	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—SRD5A1—type 2 diabetes mellitus	1.61e-05	0.000383	CbGpPWpGaD
Tolcapone—COMT—Metabolism—PPARG—type 2 diabetes mellitus	1.6e-05	0.000382	CbGpPWpGaD
Tolcapone—COMT—Metabolism—INS—type 2 diabetes mellitus	1.57e-05	0.000374	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—HSD17B3—type 2 diabetes mellitus	1.53e-05	0.000365	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—STAR—type 2 diabetes mellitus	1.53e-05	0.000365	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—ACACA—type 2 diabetes mellitus	1.53e-05	0.000365	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—ABCC8—type 2 diabetes mellitus	1.47e-05	0.00035	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—CBS—type 2 diabetes mellitus	1.47e-05	0.00035	CbGpPWpGaD
Tolcapone—COMT—Metabolism—ALB—type 2 diabetes mellitus	1.44e-05	0.000343	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—SLC5A2—type 2 diabetes mellitus	1.41e-05	0.000337	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—COX2—type 2 diabetes mellitus	1.41e-05	0.000337	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—NCOA6—type 2 diabetes mellitus	1.39e-05	0.000331	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	1.39e-05	0.000331	CbGpPWpGaD
Tolcapone—COMT—Metabolism—NOS3—type 2 diabetes mellitus	1.38e-05	0.000328	CbGpPWpGaD
Tolcapone—COMT—Metabolism—PIK3R1—type 2 diabetes mellitus	1.38e-05	0.000328	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—UCP2—type 2 diabetes mellitus	1.36e-05	0.000326	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—HSD11B1—type 2 diabetes mellitus	1.36e-05	0.000326	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—UCP3—type 2 diabetes mellitus	1.36e-05	0.000326	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	1.32e-05	0.000316	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—PCK1—type 2 diabetes mellitus	1.28e-05	0.000306	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	1.26e-05	0.000301	CbGpPWpGaD
Tolcapone—COMT—Metabolism—PTGS2—type 2 diabetes mellitus	1.26e-05	0.0003	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	1.23e-05	0.000294	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—HK1—type 2 diabetes mellitus	1.2e-05	0.000287	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	1.2e-05	0.000286	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—LPA—type 2 diabetes mellitus	1.16e-05	0.000277	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—KCNJ11—type 2 diabetes mellitus	1.16e-05	0.000277	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—GCKR—type 2 diabetes mellitus	1.16e-05	0.000277	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—HSD3B2—type 2 diabetes mellitus	1.16e-05	0.000277	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	1.12e-05	0.000266	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—ALDOB—type 2 diabetes mellitus	1.11e-05	0.000265	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	1.08e-05	0.000258	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	1.06e-05	0.000253	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	1.05e-05	0.00025	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—GLP1R—type 2 diabetes mellitus	1.03e-05	0.000247	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—SLC2A2—type 2 diabetes mellitus	9.66e-06	0.00023	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—MTR—type 2 diabetes mellitus	9.46e-06	0.000226	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—CPT1A—type 2 diabetes mellitus	9.46e-06	0.000226	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—NAMPT—type 2 diabetes mellitus	9.28e-06	0.000221	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	9.22e-06	0.00022	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—HBA1—type 2 diabetes mellitus	9.22e-06	0.00022	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—LIPC—type 2 diabetes mellitus	9.22e-06	0.00022	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—GCK—type 2 diabetes mellitus	9.22e-06	0.00022	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—CYP11A1—type 2 diabetes mellitus	9.16e-06	0.000219	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—SLC9A1—type 2 diabetes mellitus	9e-06	0.000215	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—CETP—type 2 diabetes mellitus	8.9e-06	0.000212	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	8.29e-06	0.000198	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—PSMD6—type 2 diabetes mellitus	8.27e-06	0.000197	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—SNAP25—type 2 diabetes mellitus	8.27e-06	0.000197	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—SREBF1—type 2 diabetes mellitus	8.27e-06	0.000197	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—CTGF—type 2 diabetes mellitus	8.12e-06	0.000194	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—HMGCR—type 2 diabetes mellitus	8.04e-06	0.000192	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	7.93e-06	0.000189	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—ADRA2A—type 2 diabetes mellitus	7.87e-06	0.000188	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—CYP2E1—type 2 diabetes mellitus	7.56e-06	0.00018	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—CYP1A2—type 2 diabetes mellitus	7.48e-06	0.000178	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—SLC2A1—type 2 diabetes mellitus	7.48e-06	0.000178	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—CYP3A4—type 2 diabetes mellitus	7.29e-06	0.000174	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	7.26e-06	0.000173	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—GCG—type 2 diabetes mellitus	7.17e-06	0.000171	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—SLC2A4—type 2 diabetes mellitus	7.17e-06	0.000171	CbGpPWpGaD
Tolcapone—COMT—Metabolism—AKT1—type 2 diabetes mellitus	6.33e-06	0.000151	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—GNB3—type 2 diabetes mellitus	6.18e-06	0.000147	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—PPARGC1A—type 2 diabetes mellitus	6.18e-06	0.000147	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—HMOX1—type 2 diabetes mellitus	6.15e-06	0.000147	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—CAT—type 2 diabetes mellitus	6.07e-06	0.000145	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—APOB—type 2 diabetes mellitus	5.89e-06	0.000141	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—GSTM1—type 2 diabetes mellitus	5.73e-06	0.000137	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—LPL—type 2 diabetes mellitus	5.63e-06	0.000134	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—ADCY5—type 2 diabetes mellitus	5.51e-06	0.000131	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—GPX1—type 2 diabetes mellitus	5.49e-06	0.000131	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—CD36—type 2 diabetes mellitus	5.35e-06	0.000128	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—PPP2CA—type 2 diabetes mellitus	5.28e-06	0.000126	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—MTHFR—type 2 diabetes mellitus	5.07e-06	0.000121	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—PPARA—type 2 diabetes mellitus	4.97e-06	0.000119	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—AGT—type 2 diabetes mellitus	4.81e-06	0.000115	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—CALM1—type 2 diabetes mellitus	4.73e-06	0.000113	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—APOE—type 2 diabetes mellitus	4.72e-06	0.000112	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—APOA1—type 2 diabetes mellitus	4.66e-06	0.000111	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—PPARG—type 2 diabetes mellitus	4.11e-06	9.8e-05	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—INS—type 2 diabetes mellitus	4.03e-06	9.61e-05	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—ALB—type 2 diabetes mellitus	3.69e-06	8.81e-05	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—PIK3R1—type 2 diabetes mellitus	3.53e-06	8.43e-05	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—NOS3—type 2 diabetes mellitus	3.53e-06	8.43e-05	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—PTGS2—type 2 diabetes mellitus	3.23e-06	7.71e-05	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—AKT1—type 2 diabetes mellitus	1.62e-06	3.87e-05	CbGpPWpGaD
